Can't find Amphetamine/Dextroamphetamine XR at your pharmacy? Learn why this ADHD medication is so hard to find in 2026 and what you can do about it.
You've been to three pharmacies. You've called five more. Every time, you hear the same thing: "We don't have it in stock." If you take Amphetamine/Dextroamphetamine XR — the generic version of Adderall XR — you already know how frustrating the shortage has been. And in 2026, the problem still isn't fully resolved.
Millions of Americans rely on this medication to manage ADHD (Attention Deficit Hyperactivity Disorder). When it's unavailable, it's not just an inconvenience — it can disrupt work, school, and daily life. Let's break down exactly why this medication is so hard to find and what you can do right now.
Amphetamine/Dextroamphetamine XR is an extended-release CNS stimulant used primarily to treat ADHD. It's the generic form of Adderall XR and contains a mixture of four amphetamine salts that release in two phases — some immediately and some hours later — providing symptom relief for up to 12 hours.
It's a Schedule II controlled substance, which means the federal government tightly regulates how much can be manufactured and distributed each year. This classification plays a major role in the shortage. Common strengths include 5 mg, 10 mg, 15 mg, 20 mg, 25 mg, and 30 mg extended-release capsules.
For a deeper look at this medication, check out our guide: What Is Amphetamine/Dextroamphetamine XR? Uses, Dosage, and What You Need to Know.
There isn't a single reason for the shortage — it's a combination of factors that have created a perfect storm since late 2022. Here are the main drivers:
Because Amphetamine/Dextroamphetamine XR is a Schedule II controlled substance, the Drug Enforcement Administration (DEA) sets annual limits on how much active ingredient manufacturers can produce. These quotas are meant to prevent diversion and misuse, but they also cap supply.
In October 2025, the DEA raised the aggregate production quota for d-amphetamine from 21.2 million grams to 26.5 million grams — a roughly 25% increase. While this is a positive step, it takes time for manufacturers to ramp up production, and the increase hasn't fully closed the gap between supply and demand.
Teva Pharmaceuticals, the largest manufacturer of generic Adderall XR, reported manufacturing delays starting in late 2022. Other generic manufacturers have faced similar issues, including raw material sourcing problems and quality control challenges. When one major supplier falls behind, the entire market feels the impact.
ADHD diagnoses have increased significantly in recent years, particularly among adults. The expansion of telehealth services during and after the COVID-19 pandemic made it easier for people to get evaluated and prescribed ADHD medication. More prescriptions plus limited supply equals shortages.
Unlike most medications, controlled substances face additional regulatory hurdles at every step — from raw ingredient sourcing to pharmacy distribution. Pharmacies can only order limited quantities, and distributors must comply with suspicious order monitoring. These safeguards are important, but they slow down the supply chain when demand spikes.
As of early 2026, the shortage is ongoing but improving. According to the American Society of Health-System Pharmacists (ASHP), several strengths — particularly 15 mg, 25 mg, and 30 mg extended-release capsules — remain on back order from multiple manufacturers. Some strengths like 5 mg and 10 mg are more consistently available.
The DEA's quota increase is expected to help throughout 2026, but patients should still anticipate occasional difficulty finding specific strengths at their preferred pharmacy. For the latest updates, read our Amphetamine/Dextroamphetamine XR Shortage Update for 2026.
The shortage is frustrating, but you're not powerless. Here are practical steps to improve your chances of getting your medication:
Medfinder helps you search for pharmacies that currently have Amphetamine/Dextroamphetamine XR in stock near your location. Instead of calling pharmacy after pharmacy, you can check availability online and save time.
Large chain pharmacies (CVS, Walgreens, Rite Aid) often run out first because they serve more patients. Independent and compounding pharmacies sometimes have better availability because they work with different distributors. Ask your pharmacist if they can order it from an alternative wholesaler.
If you consistently can't find your medication, your prescriber may be able to switch you to an alternative that's more readily available. Options include Vyvanse (Lisdexamfetamine), Concerta (Methylphenidate ER), or Mydayis. Learn more in our post on alternatives to Amphetamine/Dextroamphetamine XR.
Most states allow Schedule II prescriptions to be filled a few days before the current supply runs out. Ask your pharmacy about their early fill policy and plan ahead so you're not caught without medication.
If your usual strength is unavailable, ask your doctor if you can use a different combination of strengths to reach the same daily dose. For example, two 10 mg capsules instead of one 20 mg capsule.
The Amphetamine/Dextroamphetamine XR shortage has been one of the most disruptive medication shortages in recent years. While there are signs of improvement in 2026, patients still face real challenges filling their prescriptions. The best things you can do are stay informed, use tools like Medfinder to find stock near you, and keep an open line of communication with your prescriber.
If cost is also a concern, check out our guide on how to save money on Amphetamine/Dextroamphetamine XR.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.
%2C%20Color%3DOriginal.png)
